Mesa Laboratories Inc (MLAB)

Debt-to-equity ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Long-term debt	US$ in thousands	171,198	170,965	170,733	170,502	170,272	170,044	169,816	169,590	169,365	229,140	168,917	168,695	145,675	144,302	142,945	141,604	140,278	138,967	137,682	17,512
Total stockholders’ equity	US$ in thousands	145,393	402,961	387,759	387,719	393,480	387,205	374,236	380,431	393,801	396,329	399,417	399,003	406,227	412,795	392,412	382,234	220,013	235,260	230,246	119,047
Debt-to-equity ratio		1.18	0.42	0.44	0.44	0.43	0.44	0.45	0.45	0.43	0.58	0.42	0.42	0.36	0.35	0.36	0.37	0.64	0.59	0.60	0.15

March 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $171,198K ÷ $145,393K
= 1.18

The debt-to-equity ratio of Mesa Laboratories Inc has shown fluctuations over the past few quarters. As of March 31, 2024, the ratio stands at 1.18, indicating that the company has more debt relative to its equity. This represents a significant increase from the previous quarter's ratio of 0.42.

Looking back at the trend, the ratio has been volatile with values ranging from as low as 0.15 to as high as 1.18. Mesa Laboratories Inc experienced a notable increase in leverage between December 2021 and March 2024, which may suggest a change in the company's capital structure or funding decisions during this period.

It is important to further investigate the reasons behind the fluctuation in the debt-to-equity ratio to understand the company's financial health and risk profile. Changes in this ratio could impact the company's ability to meet its financial obligations, leverage its operations efficiently, and manage potential risks associated with its capital structure.